Support Our Work

Please donate so we can continue our work to reduce the stigma of psychiatric illness, encourage research, and support educational activities for behavioral health professionals and the public. Ways you can donate and help are on our Support and Donations page. Thank you!

More Info

Latest News Around the Web

Antidepressant Use Associated With Lower Prevalence Of Periodontitis, Study Says

HealthDay (11/20, Solomon) reports a study published in the Journal of Periodontology links antidepressant use “to a lower prevalence of periodontitis.” Investigators “found that the overall prevalence of periodontitis was 35.3 percent for moderate and 11.1 percent for severe cases, with antidepressant use associated with reduced odds of developing periodontitis across most definitions.” The identified “association was particularly strong for severe cases.”

Related Links:

— “Antidepressant Use Tied to Lower Prevalence of Periodontitis,”Lori Solomon, HealthDay, November 20, 2025

The American Journal of Managed Care

HealthDay (11/19, Thompson) reports a review published in Psychological Trauma: Theory, Research, Practice, and Policy found that one in four “US service members and veterans who start psychotherapy for PTSD quit before they finish treatment.” The review also found that “trauma-focused approaches like exposure therapy and cognitive processing therapy tended to have higher dropout rates than approaches focusing on mindfulness, meditation and stress reduction.”

Related Links:

— “Some PTSD Therapy Approaches Prompt More Veterans To Flee Treatment,”Dennis Thompson, HealthDay, November 19, 2025

Sustaining Meaningful Engagement With Mental Health Apps For Depression And Anxiety Remains Challenging, Analysis Says

The American Journal of Managed Care (11/19, Steinzor) reports, “A new meta-analysis of 79 randomized trials reveals that while most users activate” mental health apps for depression and anxiety, “sustaining meaningful engagement remains challenging.” The analysis, published in JAMA Psychiatry, “identifies strategies – including reminders and human support – that can reduce dropout and improve adherence, providing evidence-based guidance for designing more effective digital mental health interventions.”

Related Links:

— “Addressing Uptake, Adherence, and Attrition in Mental Health Apps,”Pearl Steinzor, The American Journal of Managed Care , November 19, 2025

Patients With Alzheimer Disease Who Also Have Depression, Anxiety, Or PTSD Experience Symptom Onset Several Years Earlier Than Those Without Psychiatric Comorbidities, Study Finds

Neurology Advisor (11/18, Saha) reports a study found that “individuals with Alzheimer disease (AD) who also have depression, anxiety, or post-traumatic stress disorder (PTSD) experience symptom onset several years earlier than those without psychiatric comorbidities.” Researchers observed that among study participants diagnosed with probable AD, “43.3% of patients had a history of depression, 32.3% had anxiety, and 1.0% had PTSD. Patients with these conditions experienced AD onset 2.2 years earlier (depression), 3.0 years earlier (anxiety), and 6.8 years earlier (PTSD) than those without them. A clear dose-response relationship was observed, in which having 1 psychiatric condition reduced the age at onset by 1.5 years, 2 conditions by 3.3 years, and 3 or more by 7.7 years.” A second cohort of participants from the National Alzheimer’s Coordinating Center (NACC) “reinforced these results. Participants with depression or anxiety developed AD 2.1 years earlier than those without either condition.” The study was published in Alzheimer’s & Dementia.

Related Links:

— “Psychiatric Comorbidities Associated With Earlier Onset of Alzheimer Disease,”Rajan Saha, Neurology Advisor , November 18, 2025

Mood-Stabilizing Medications Vary In Dermatologic Side Effects, But Severe Dermatologic Adverse Events Are Rare, Analysis Finds

Psychiatric News (11/18) reports, “Mood-stabilizing medications vary in their dermatologic side effects, but severe dermatologic adverse events are rare,” according to findings from a meta-analysis published in the Journal of Psychiatric Research. Researchers found that “the most common dermatologic adverse event was rash, reported in 9.2% of patients who took lamotrigine, 6% who took carbamazepine, 2.9% who took valproate, and 1.3% who took lithium.”

Related Links:

— “Mood Stabilizers Vary in Skin Side Effects, but Severe Events Are Rare, Psychiatric News, November 18, 2025

Foundation News

PRMS Highlights Maryland Foundation for Psychiatry

Professional Risk Management Services, Inc. (PRMS) just posted a wonderful piece on its blog noting the many successful initiatives of the Maryland Foundation for Psychiatry. The information is also included in their Twitter and LinkedIn (see links below). PRMS has been a generous donor to the Foundation in addition to this excellent promotion of the significant role that it plays in our state.

Related Links:

Blog Post
Twitter
LinkedIn

New Foundation Radio Ad Examines #MeToo Trauma

Starting February 5, 2018, the Foundation will begin airing a new public service ad on area radio stations. It specifically examines the long term effects of trauma evidenced by the #MeToo movement as well as recent prosecution of abusers, such as the trial of the former doctor for the Olympic gymnastics team. Those effects range from anxiety disorder to suicide, and help is available for all of them.

#Metoo trauma can have long-term mental health consequences#Metoo trauma can have long-term mental health consequences, MP3, 1.5MB

You can listen to the ad using the player in the upper right of the website’s homepage. All past public service spots are also available for listening or to download on our Radio Advertisements page.

Foundation’s Oral History Project To Go Online

As reported in the Maryland Psychiatric Society News, the Foundation’s Oral History Project is well on its way. The project is designed to collect fascinating stories about psychiatrists from different backgrounds who entered a career path that brought them to Maryland. There are nineteen interviews already archived at MPS, and the Foundation is seeking more. You can find more information about the project as well as get information on contacting the Foundation here:

Oral History Project

Latest Foundation Radio Ad Discusses Police Training and the Mentally Ill

The Maryland Foundation for Psychiatry, Inc.’s latest public service announcement on local Maryland radio stations focuses on how police in Baltimore are being trained to recognize the signs and symptoms of a whole range of mental health conditions and hopefully avoid tragedies.

Training helps police help the mentally illTraining helps police help the mentally ill

You can listen to the ad using the player in the upper right of the website’s homepage. All past public service spots are also available for listening or to download on our Radio Advertisements page.

New Foundation PSA Examines College and Drug Use

The Maryland Foundation for Psychiatry, Inc.’s latest public service announcement on local Maryland radio stations. When does most drug abuse start in college? Right now – finals and summer. According to studies half a million students started drug and alcohol abuse just in the past year. The PSA examines prevention and treatment, especially at this early age.

College and First Use of Drugs and AlcoholCollege and First Use of Drugs and Alcohol, MP3, 2.4MB

You can listen to the ad using the player in the upper right of the website’s homepage. All past public service spots are also available for listening or to download on our Radio Advertisements page.